Credit: Kyle LaHucik

#AS­CO22: Min­gling face-to-face stole the spot­light in re­union with '50,000 of your clos­est friend­s'

CHICA­GO — This week­end, tens of thou­sands of physi­cians, clin­i­cal tri­al in­ves­ti­ga­tors, aca­d­e­mics, R&D sci­en­tists and bio­phar­ma lead­ers de­scend­ed up­on Chica­go for the first in-per­son AS­CO meet­ing since the pan­dem­ic on­set.

Be­ing in-per­son was the “big thing,” as Foun­da­tion Med­i­cine’s Bri­an Alexan­der told me. That re­mark was made be­fore the En­her­tu da­ta drop.

“It’s such a fun place to be with 50,000 of your clos­est friends,” Zymeworks’ Ken­neth Gal­braith said out­side one of the con­ven­tion cen­ter’s mul­ti­ple Star­bucks.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.